SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2096)1/7/2008 12:12:53 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
MRK Is trying to get off the DT coming from its Dec 12 H at $61.62

bigcharts.marketwatch.com

In spite of its legal problems from Vioxx, MRK reported better revenues & earnings in the last 3Qs.The pending 4thQ results are also expected to be better than the $0.50 in 2006. The EE for 2007 are around $3.15 vs. $2.52 in 2006 & for 2008 further improvement to around $3.40 is expected.<g>

The short ratio came down some in the last month & is now < 2x its ADV. MRK has around $3.50 in +CF

Once the stock can close above its Dec H, it will make a 5Yrs H.It seems that it could get to trade around its April 2001 H of $76.49 this Yr.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2096)1/9/2008 11:56:17 AM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
OSIR Has closed most of the UG of Jan 4.It is holding above the $13 level.

bigcharts.marketwatch.com

On Jan 4 was when it announced that it received an order valued at up to $224.7M from the U.S. DD for Prochymal, an adult SC therapy for gastrointestinal injury resulting from radiation.

bigcharts.marketwatch.com

Bernard